Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 8.30
+0.10 (1.22%)
At close: Mar 9, 2026
Central Pharmaceuticals Revenue
Central Pharmaceuticals had revenue of 8.93M BDT in the quarter ending September 30, 2025, a decrease of -79.29%. This brings the company's revenue in the last twelve months to 33.51M, down -70.02% year-over-year. In the fiscal year ending June 30, 2025, Central Pharmaceuticals had annual revenue of 33.06M with 11.68% growth.
Revenue (ttm)
33.51M
Revenue Growth
-70.02%
P/S Ratio
29.68
Revenue / Employee
446.74K
Employees
75
Market Cap
994.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 33.06M | 3.46M | 11.68% |
| Jun 30, 2024 | 29.60M | 271.46K | 0.93% |
| Jun 30, 2023 | 29.33M | 3.33M | 12.81% |
| Jun 30, 2022 | 26.00M | -122.15M | -82.45% |
| Jun 30, 2021 | 148.15M | 8.06M | 5.75% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Advent Pharma | 516.48M |
| Silva Pharmaceuticals | 356.99M |
| Silco Pharmaceuticals | 428.63M |
| Libra Infusions | 197.03M |
| Indo-Bangla Pharmaceuticals | 198.02M |
| Pharma Aids | 453.49M |
| Ambee Pharmaceuticals | 193.90M |
| Techno Drugs | 3.15B |